Participated · Equity · May 2026

Signos offers an FDA-cleared, over-the-counter continuous glucose monitoring (CGM) system combined with an AI engine that scores meals and activities based on each user's glucose responses. The platform provides personalized feedback to help users understand which foods and behaviors drive glucose changes and to track trends toward weight-management goals. Signos positions its offering as complementary to GLP-1 medications by providing metabolic self-knowledge that supports long-term results. The company has grown tenfold over the past six months and is expanding distribution through a partnership with Dexcom, which will make Signos available on Stelo.com. Signos was founded in 2018 with a stated mission to eliminate obesity, and its product requires no prescription. The recent $20 million raise is intended to accelerate the company's growth and broaden access to its system.

Participated · Series C · May 2019

Solera Health operates the HALO platform, a marketplace that connects payers, employers, and individuals to clinically validated digital health applications and turnkey programs. The company plans to expand the Solera HALO platform by building the HALO Cloud to unite its network of point solutions and simplify integration of hundreds of digital health applications. Solera has recently added virtual specialty care and solutions targeting cardiometabolic conditions such as hypertension, high cholesterol, diabetes prevention, and weight management. It also announced a strategic collaboration with professional services firm Aon to enable employers to deliver personalized health experiences and engage high-risk employees. Leadership changed when John Santelli, who joined in March 2024, transitioned from interim CEO to chief executive officer and intends to deepen integration into customers’ operations. Financially, Solera announced $40 million in new funding to support product expansion and operational scaling of its HALO technology and services. Solera Health is a Phoenix, AZ-based platform that supports an ecosystem of community and digital partners matching health plan members to chronic disease prevention and management, social determinants of health (SDOH) and behavioral health. Led by CEO Brenda Schmidt, the company serves as an integrated benefit network that connects patients, payers and physicians with community organizations and digital therapeutics providers. Solera consolidates fragmented programs and services into a single marketplace, allowing health plans and medical providers to increase consumer participation while lowering associated costs. The company raised $42M in Series C financing, bringing total funding to date to $72M. It intends to use the funds to address behavioral health and SDOH needs such as food insecurity, medically tailored meals, transportation, falls prevention and social isolation. Over the past 12 months Solera has expanded its network to support a broader array of lifestyle modification programs, including diabetes management, hypertension, stress, sleep, tobacco cessation and weight management. Solera Health provides integrated chronic disease prevention services that connect patients, payers and physicians with community organizations and digital therapeutics providers. It consolidates fragmented programs and services into one integrated network to increase consumer participation and lower associated costs for health plans and medical providers. Solera has built a national network of community organizations and digital DPPs including Weight Watchers, Lark, Retrofit and Noom. Since launch the company has grown to over 70 employees and has over 40 million covered lives under contract. Led by CEO Brenda Schmidt and based in Phoenix, AZ, Solera intends to use the new funding to expand its offering and business reach. The company has raised $30.3M in total to date. Solera Health is a technology-enabled personalized preventive health network that operates a marketplace connecting U.S. adults at risk for type 2 diabetes with CDC-recognized Diabetes Prevention Programs (DPPs). Led by CEO Brenda Schmidt and based in Phoenix, AZ, the company aggregates more than 850 digital, national, and community-based DPPs into one integrated network. Its national model was designed to consolidate fragmented programs and services to increase consumer access and participation while lowering associated costs for health plans and medical providers. Strategic partnerships include HealthSlate, Blue Mesa Health, Noom, Retrofit, Canary Health, Weight Watchers and organizations such as the Black Women Health Imperative. The company has raised $7M in total funding and recently closed a $4M Series A1 round. Solera will use the new funds to scale operations for the National DPP as a covered health benefit. Solera Health operates a proprietary SaaS platform that connects a national network of local community organizations and digital solutions to deliver chronic disease prevention programs. The platform supports administration and streamlining of National Diabetes Prevention Program (DPP) referrals, reimbursement and payment management, and aggregation of data and reporting. Its services simplify enrollment and support consumer engagement and choice for DPP offerings led by the CDC. The company is led by founder and CEO Brenda Schmidt and is based in Phoenix, AZ. Solera positions itself as a technology-enabled integrator across local and digital program providers to increase access to prevention services. It plans to use recent funding to advance its technology platform and scale operations.